Acadia Healthcare Co. (NASDAQ:ACHC) had its target price reduced by analysts at Royal Bank Of Canada from $78.00 to $59.00 in a research report issued on Wednesday. The brokerage presently has an “outperform” rating on the stock. Royal Bank Of Canada’s price target would indicate a potential upside of 30.56% from the company’s previous close.
Several other research firms also recently commented on ACHC. Zacks Investment Research upgraded shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a research report on Monday, October 3rd. JPMorgan Chase & Co. reiterated a “hold” rating and set a $61.00 target price on shares of Acadia Healthcare in a research report on Tuesday, September 27th. Leerink Swann reiterated an “outperform” rating and set a $80.00 target price on shares of Acadia Healthcare in a research report on Monday, September 26th. Robert W. Baird cut their target price on shares of Acadia Healthcare from $67.00 to $66.00 and set an “outperform” rating on the stock in a research report on Thursday, September 15th. Finally, RBC Capital Markets reiterated an “outperform” rating and set a $78.00 target price (down from $86.00) on shares of Acadia Healthcare in a research report on Monday, August 1st. Two investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $75.86.
Acadia Healthcare (NASDAQ:ACHC) opened at 45.19 on Wednesday. The stock has a 50 day moving average of $49.05 and a 200 day moving average of $54.52. The firm has a market cap of $3.95 billion, a PE ratio of 24.14 and a beta of 0.86. Acadia Healthcare has a 12-month low of $42.47 and a 12-month high of $74.77.
Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Friday, July 29th. The company reported $0.73 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.73. Acadia Healthcare had a net margin of 6.44% and a return on equity of 9.35%. The company had revenue of $756.50 million for the quarter, compared to the consensus estimate of $752.57 million. During the same period last year, the company posted $0.57 EPS. The firm’s quarterly revenue was up 66.8% compared to the same quarter last year. On average, equities research analysts anticipate that Acadia Healthcare will post $2.63 EPS for the current fiscal year.
In other news, Director Reeve B. Waud sold 1,360,977 shares of Acadia Healthcare stock in a transaction on Friday, September 16th. The shares were sold at an average price of $48.52, for a total value of $66,034,604.04. Following the completion of the sale, the director now owns 55,673 shares in the company, valued at approximately $2,701,253.96. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Ronald Morgan Fincher sold 8,800 shares of Acadia Healthcare stock in a transaction on Monday, August 8th. The shares were sold at an average price of $52.56, for a total transaction of $462,528.00. Following the completion of the sale, the chief operating officer now owns 120,780 shares of the company’s stock, valued at approximately $6,348,196.80. The disclosure for this sale can be found here. 17.20% of the stock is currently owned by insiders.
Several hedge funds have recently added to or reduced their stakes in the stock. Advisory Services Network LLC raised its stake in shares of Acadia Healthcare by 5,542.1% in the third quarter. Advisory Services Network LLC now owns 2,144 shares of the company’s stock worth $106,000 after buying an additional 2,106 shares during the period. American International Group Inc. raised its stake in shares of Acadia Healthcare by 71.7% in the second quarter. American International Group Inc. now owns 2,218 shares of the company’s stock worth $123,000 after buying an additional 926 shares during the period. Advisor Group Inc. acquired a new stake in shares of Acadia Healthcare during the second quarter worth approximately $166,000. Springbok Capital Management LLC raised its stake in shares of Acadia Healthcare by 101.3% in the first quarter. Springbok Capital Management LLC now owns 3,741 shares of the company’s stock worth $206,000 after buying an additional 1,883 shares during the period. Finally, Jane Street Group LLC acquired a new stake in shares of Acadia Healthcare during the second quarter worth approximately $210,000.
About Acadia Healthcare
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services. The Company operates in two segments: U.S. Facilities and U.K. Facilities. The Company develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities throughout the United States, the United Kingdom and Puerto Rico.
Receive News & Ratings for Acadia Healthcare Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Co. and related companies with MarketBeat.com's FREE daily email newsletter.